K-Bro Linen Inc. (KBL) Earnings Call Transcript
August 5, 2026
Earnings Call Speaker Segments
Good morning, everyone, and thank you for joining the K-Bro Linen Systems Incorporated call covering second quarter 2026 results. Right now, every line has been placed in listen-only mode. After the presentation, there will be a question-and-answer session. Should you need immediate assistance at any point during this call, simply press star zero to reach the operator. Today is Wednesday, August 5th, 2026, and this call is being recorded. I'll now hand the conference over to Kristie Plaquin. Please go ahead.
Thank you, Operator, and good morning to all of you. We appreciate your joining us today and welcome you to the conference call covering our second quarter results. With me on the line this morning is Linda McCurdy, our President and Chief Executive Officer. Before we get started, I want to remind everyone that any statements in our prepared remarks on this call that refer to management's expectations or to our predictions about the future are forward-looking statements. Everything said today that is not a statement of historical fact is considered a forward-looking statement. Certain material factors or assumptions were applied when drawing a conclusion or making a forecast or projection as reflected in the forward-looking information. Investors are also cautioned against placing undue reliance on these statements. Actual results could differ materially from those anticipated. The risk factors that could affect the results are detailed in the corporation's public filings. I'll now hand the call over to our CEO, Linda McCurdy, who will share her insights and remarks on the quarter. Linda?
Thanks so much, Kristie, and good morning, everyone. We appreciate you being with us today as we go over the results for the second quarter of 2026. I'll go over a few of the quarter's highlights, and after that Kristie will walk through some specifics regarding our financial performance and our balance sheet. Our strong second quarter results please us, and they line up with what we had expected. Revenue came in at $150 million for the quarter, while adjusted EBITDA reached $29.8 million. Trends have been steady across both our healthcare and hospitality segments. The Q2 results demonstrate the advantage of our strategic national platforms in Canada and the UK alike. We marked our first full year of ownership of Stellar Marion on July 11th, and we're happy with how our integration work is progressing. Our expectation remains that run rate cost synergies will be delivered across the contemplated 24-month time horizon. As of the end of Q2, we estimate that we have captured approximately 40% of the anticipated synergies. Consolidated total revenue for the quarter rose 33% versus 2025, as healthcare revenue grew 50% and hospitality revenue grew 15%. Healthcare revenues accounted for roughly 58% of our consolidated revenue, up from approximately 51% in '25, reflecting the acquisition of Stellar.
Even with the global environment turning more volatile, we're happy with how Q2 came out, which highlights both our resilient growth model and the performance of the business. Our seasoned team, as it always does, remains focused on disciplined operations. At this point I'll hand the call to Kristie so she can walk through our detailed financial results for the quarter, and then I'll come back and speak with you about the outlook. Many thanks. Kristie, the floor is yours.
Thanks, Linda. The information we're covering today also appears in the 2026 second quarter earnings press release that went out yesterday, and you can find detailed supplemental financial information on our Investor Relations website under the Financials heading. K-Bro's consolidated revenue for Q2 2026 rose 33% year-over-year to $150.4 million. Measured in Canadian dollars, quarterly revenue from the Canadian and UK divisions was roughly even, with Canada at 47.7% and the UK at 52.2%. Growth in consolidated revenues stems mainly from the June 2025 acquisition of Stellar Marion, along with the effect of price increases we put in place. Consolidated adjusted EBITDA for Q2 2026 was up 25.6% year-over-year to $29.8 million. Consolidated adjusted EBITDA margin fell 1.2% year-over-year to 19.8%, mostly reflecting the combination of the Stellar Marion margin profile and higher fuel costs. In the Canadian division, adjusted EBITDA margin held relatively steady in the second quarter at 21.1%. In the UK division, adjusted EBITDA margin for the second quarter declined 2.1% to 18.6% in 2026. That decrease is mainly tied to the combination of the Stellar Marion margin profile and higher fuel costs. Adjusted net earnings rose in the second quarter of 2026 to $10.1 million from $7.8 million in 2025, including adjusting items of $2.5 million.
Within this quarter, the adjusted figures consist of reduced transaction expenses and structural financing charges tied to the Stellar Marion purchase, transition outlays, a fair value adjustment on interest rate derivatives — something I'll cover in greater depth shortly — non-recurring gains, plus amortization of intangible assets. K-Bro generates robust cash flow and takes a disciplined stance on allocating capital, which lets us put money into expanding the business while also giving capital back to shareholders. Distributable cash flow for Q2 2026 came to $14.7 million, with a payout ratio of 26.6%. On a trailing 12-month basis, our payout ratio stood at 27.3%. During the quarter, the company distributed $0.30 per share in dividends, amounting to $3.9 million in total consideration. K-Bro bought back and canceled 58,000 common shares in Q2 for $2.5 million through the normal course issuer bid. Following the acquisition, debt and leverage levels are in line with what we expected. Our balance sheet is strong, with substantial undrawn room on the syndicated revolving credit facility — an operating line of $175 million, an amortizing term loan of $134.3 million, and an additional $50 million accordion earmarked for growth. As of the close of Q2 '26, we had an undrawn balance of nearly $69.6 million on the operating line, excluding the accordion, which underscores our solid liquidity.
On a pro forma basis, this works out to a funded debt-to-EBITDA ratio—excluding leases—of slightly below 2.5 times. As of the period that closed on June 30th, '26, debt to total capitalization stood at 47.5%, while total debt, net of cash, came to $213.5 million. K-Bro faces exposure to floating interest rates, and movements in those rates could affect future cash flows. In June, to manage that exposure to interest rate fluctuations, K-Bro put in place an interest rate swap tied to the term loan portion of its syndicated credit facility. Through this swap's terms, K-Bro effectively moves the floating interest rate exposure on the term loan into a fixed rate. The interest rate swap gets measured at fair value and is recorded as interest rate derivatives on the consolidated statement of financial position, while changes in fair value are recognized in fair value adjustment on interest rate derivatives within operating costs in the consolidated statement of income. Realized gains and losses from the interest rate swap are recognized in finance expense, matching how interest on the underlying term loan is presented. The fair value adjustment on interest rate derivatives is treated as an adjusted item, as laid out in the tables in the terminology section of our MD&A.
Now I'll hand the floor back to Linda, who has some further remarks to share. Linda?
Thank you, Kristie. We're happy with how 2026 has begun, and against a shifting macro backdrop, our outlook looks favorable. With Stellar having joined us in 2025, K-Bro now stands as Canada's biggest processor of laundry and linen for healthcare and hospitality clients, and ranks among the biggest in the UK, holding nationwide geographic coverage from coast to coast in both countries. From a network of strategically placed facilities, we can provide industry-leading service to healthcare and hospitality customers. The continuity of our customers' operations depends on the services we provide. Our team is highly experienced, and our focus is on disciplined operational performance. Last week, we announced that John Lynch is joining the board. For 10 years, John served as a Managing Director at J.P. Morgan Asset Management, where he grew and managed the infrastructure investments and team in Europe. John adds a breadth of capital markets experience to the board, among it more than three decades spent in international finance and investing, and all of this will make K-Bro's board of directors even stronger. We're very excited to have John on board. Our UK integration efforts have moved along well. As we've noted previously, during the past year we put a variety of improvements in place at Stellar, among them bringing the maintenance function in-house, optimizing workflows, realigning compensation structures, replacing certain managers, and drawing on the depth of K-Bro's talent.
Our UK national platform ranks among the top three players, and we're strongly positioned for long-term growth in healthcare and hospitality. On a consolidated basis, we keep watching the shifting global economic and political forces. As things stand today, steady growth continues in both of K-Bro's healthcare and hospitality segments. Looking ahead, we expect combined adjusted EBITDA margins to stay at levels similar to seasonally adjusted combined historical margins. Consistent with our expectations, because Stellar carries a lower EBITDA margin profile, the consolidated UK divisional adjusted EBITDA margins will come in below seasonally adjusted historical margins. We remain watchful of the volatile energy pricing environment and how it affects diesel prices and our margins. In the UK, 50% of our diesel usage is hedged, while 50% is floating. In Canada, our diesel usage is floating. Management estimates that diesel rates negatively impacted Q2 2026 adjusted EBITDA margins by half a percentage point. If diesel rates hold steady, management anticipates that the adjusted EBITDA margin for the remaining quarters in 2026 will keep being impacted by this same magnitude. As we mark Stellar's first anniversary, our focus is on completing the integration, pursuing organic growth opportunities, and potential M&A opportunities.
Acquiring top-tier operators strategically remains a key driver of our growth profile and overall strategy. We're happy with how our recent acquisitions have contributed early on and think they will strengthen our growth profile further. We assess possible strategic acquisitions that might fit well with our platform, and if such opportunities come up, we'll aim to use our solid liquidity position, balance sheet, and capital markets access to act on them. Putting people first, being dependable partners, and embracing environmental stewardship have long been part of our culture, and we're dedicated to a sustainable future. At this point I'll turn it over for any questions you might have regarding the quarter. Operator?
Thank you. Ladies and gentlemen, the question-and-answer portion of today's call starts now. If you'd like to ask something, press star then one on your touchtone phone. A prompt will confirm that your hand has been raised. If you'd rather withdraw from the polling process, press star then two. Those of you on a speakerphone should lift the handset before pressing any keys. Our first question comes from Cheryl Zhang of TD Cowen.
Morning, Linda and Kristie. Appreciate you both for fielding my question today. First thing I wanted to raise is the synergy capture. I'm curious whether you could speak to the additional Stellar Marion synergy realized during Q2, and how much is still left to achieve?
Thanks, Cheryl. We feel really good about how far we've come. I laid out several of the areas we've been concentrating on so far. Our estimate is that roughly 40% of the targeted synergies are in hand, and we'll capture the rest across the next 12 months. The biggest remaining hurdle is moving our healthcare plants to seven-day working. One plant has already made the switch, and that went well, but the tougher transition will come in the healthcare plants. Planning is already well advanced, and we expect that to take place over the coming six months. It's a major shift in how people work and, clearly, in their schedules. Everyone had weekends off, so we need to be very careful and thoughtful about how this is rolled out. As I said, among the key accomplishments so far is bringing the whole engineering function and maintenance function back in-house, and that has gone extremely well. We've made management changes, we've collaborated with our customers to chase additional volumes, and we're very happy with the progress, though there's certainly more ahead, Cheryl.
That's quite useful context, so thanks, Linda. Turning to hospitality for my next question: Canadian hospitality expansion, as I understand it, decelerated to 0.9% during this quarter. I'd be curious whether you can shed some light on that, and also whether any pullback in travel activity has shown up? Perhaps I could pose the same question regarding UK hospitality too — I'm just wondering how organic growth and volume have been trending there.
Absolutely, and thanks for asking. From a hospitality growth standpoint, I'd say Q2 compared with earlier years was certainly below the year-over-year trend we've been used to. One thing worth highlighting is FIFA, which had an effect on both Toronto and Vancouver, where occupancy levels fell short of expectations. My sense is that a big block of rooms got held aside for FIFA. Those rooms weren't taken up or filled, they were available to the general public, but pricing was extremely high. Hotel rates were very high indeed, and travelers decided against coming. That had an impact on the Toronto and Vancouver markets alike. In the UK, I'd note they dealt with severe heat, and volumes along with occupancies came in somewhat softer than what history would suggest. It's somewhat unclear what that implies for Q3, though growth continues, just possibly not at the level we've historically seen. In Canada, it tied very directly to the effect of unsold rooms related to FIFA. What that means going forward, though, is somewhat unclear.
All right, that context is useful. Appreciate it. I’ll rejoin the queue.
Appreciate that, Cheryl.
Thanks. Our following question comes from Hanzo Sars at ATB Cormark.
Hi there, I'm filling in for Kyle McPhee. We're looking for an update on the hedge book, particularly for diesel and natural gas. My key question is whether any new hedges have been put in place since the last quarterly update that would change your margin exposure risk in 2027. I realize that no matter how things unfold, you're able to recover potential margin drag over time given your kind of pricing power, but we simply want to get a handle on that transient risk in 2027 if diesel and gas prices don't ease. Thank you.
Yes, and thanks for asking. Kristie, I'll have you take that one.
Sure. Since our Q1 call, no further hedges have been put in place. Our guidance, honestly, would stay pretty much the same. As Linda said, roughly 50% of the natural gas we use in the UK is hedged, while the other 50% floats, and in Canada everything floats. If diesel rates stay where they are, we'd see roughly a half a percent exposure to the margin. Looking at natural gas, most of our Canadian hedges unwind across multiple years. Right now we aren't seeing major volatility in Canadian natural gas prices, particularly since we have no significant hedges rolling off in 2027. In the UK, natural gas costs today sit a bit above where our existing hedge is. If we had to lock in prices at present, that would hit the margin negatively by around half a percent too.
All right, understood. Then on Q2 margins specifically, the result came in stronger than our expectation. Did pricing moves let you counter the diesel inflation hit, or would you credit that margin outcome to another factor that worked strongly to your advantage?
Yeah. I think several factors played a part. Some of our distribution routes have been optimized. We've seen certain areas where prices went up. Labor costs have stayed nicely in check, partly because new equipment has been installed. Kristie, is there anything else I'm leaving out from the list of contributing factors? No, you covered the highlights. Yeah.
That's really helpful context. I appreciate it.
Thanks. Our following question comes from Ahmed Abdullah at National Bank of Canada.
Yeah, thanks. Morning, everyone. To expand a bit further on margins: your Canadian margin held steady compared with last year, even with the obvious wage and diesel cost pressures. Let me frame the question a bit differently — what share of that resilience came from pricing, route optimization, and other initiatives, and maybe volume too, and how much of those gains do you expect to carry into the second half?
My answer would be that it's a mix of the two, roughly 50-50, Ahmed. Our sense is that it's fair to anticipate this carrying on through the rest of the year. We felt good about what we achieved in holding costs down and in offsetting the higher diesel expenses via efficiencies and other areas.
All right. Even though there’s no hedge in place on diesel costs, you can still work around it and soften the impact as much as you can. Is that roughly the takeaway I should have here?
Yes. Savings from other areas too. Route consolidation definitely played a part, along with labor, and then, as I said, higher prices elsewhere. We believe that through Q3, that will remain within reach.
Alright, a question about something we picked up after you reported Q4: there's a fairly large linen purchase obligation sitting on your books. Does that back a new contract win, or is it to replace some aged inventory you're holding? Any detail on that we ought to keep in mind?
Kristie, that one's yours.
Linda, I can address that one. No, this isn’t tied to a new contract win. I think what we’re really seeing is just a timing matter regarding when we issued purchase orders for standard linen orders. We probably placed those earlier this year than in prior years, but it’s really more routine linen buying.
Alright, that gives me useful context. One final question from my end. Linda, is there anything new to share regarding the request-for-proposal processes over in eastern Canada?
There's nothing formal for us to report. I'd say we remain optimistic, and it's something worth discussing; plus, with those expiring, we feel good about it.
All right, that’s useful. I’ll hand over the call. Thanks so much.
Thanks. The next question is from Michael Glen at Raymond James. Michael, maybe your line is muted? It's open. I'm not getting any response. So I'll move on to the following question. That one comes from Justin Keywood at Stifel.
Morning, everyone. Appreciate you having me on the call.
Morning there, Justin.
Hey there. Regarding that RFP opportunity, could you give us an update on where things stand with the Ontario situation and the GTA hospitals? Should we expect any RFPs to hit the market this year, and what might that opportunity look like as we head into next year as well?
My sense is this will vary from one hospital to the next, and I do expect more activity in Q3 and Q4, and on into 2027 as well. Pinpointing the potential dollar value is tough, I think, but something in the range of $10 million plus is roughly what we believe exists in the short-to-medium term.
Linda, is that the total worth of the RFPs? My assumption is that a number of hospitals are included in that figure?
Sure. Yeah, so again, near term, I believe some hospitals could stretch things out—and by near term I mean perhaps 1 or 2 years—but across the coming 2 to 3 years, I think it will be considerably more than $10 million; that said, I'd say the $10 million would pertain to a window of the next 6 to 6 to 12 months.
Got it — thanks, that's really useful. Then about the Vancouver contract, which is due to renew next year, if I'm not mistaken — can you give us an update on where that process stands, or is it still a little too early for that?
This is a competitive process, so I won't say too much about it beyond noting that we operate a very large, efficient, state-of-the-art plant and have served that market since 2000. We feel very good about where we stand, while recognizing that the process is a competitive one.
Thanks. Regarding acquisitions, that board appointment is quite interesting—does it indicate there are further opportunities in Europe? I understand this might be hard to answer, but it would help if you could put that opportunity into context. And is there a target percentage of sales for hospitality versus healthcare? The healthcare share has crept up somewhat—it reached 57% in the quarter—so I'm curious whether there's a medium- or long-term target overall. Thank you.
Justin, it's not truly a target, honestly. What it really boils down to is: where are the compelling opportunities, solid acquisition candidates — contracts included, strong management, and where are they situated geographically, plus what quality do the assets have. Between healthcare and hospitality we're somewhat agnostic; each is profitable and a meaningful component of our growth strategy. As for the board addition, the fact is more than 50% of our top line now originates from the UK. We felt it was very, very important to bring in someone with a UK perspective, English, acquainted with the English market and that country's business environment. I'd say it had been in the works for some time. We're very pleased with the addition. Regarding future acquisitions — size, number — we stay optimistic that interesting and attractive opportunities exist out there. I think I've remarked that the quantum, size, and number of them is probably higher in the UK; there's still greater fragmentation in the UK market. On size, probably — we obviously completed the largest acquisition of Stellar, and the size of those is reduced substantially now that asset has been acquired by us, but there are a number that are more of the short-ridge size in the UK market.
Canada does have acquisitions, though its market has consolidated to a greater degree than the UK's.
Thanks. That's really useful. I'm eager to see what comes next.
Much appreciated, Justin.
Our following question comes from Michael Glen at Raymond James.
Apologies for the earlier mix-up. Linda or Kristie, regarding the AR build this quarter — that increase in accounts receivable — would you anticipate that reversing in Q3?
Yeah, that's genuinely seasonality — Q2 is a far stronger quarter than Q4, so that's the comparison. It really comes down to when our customers make their payments across those two quarters, and that's because volumes are higher.
Alright, regarding the buyback program, Linda — should we anticipate that the repurchase activity keeps running at comparable levels? I'm just trying to get a sense of the thinking behind the NCIB going forward.
This is something we watch very closely on an ongoing basis, I'd say. As we explained, repurchases came to more than $2 million, and we'll keep monitoring it while keeping leverage and growth opportunities in mind going forward. We've been active in it, and we remain active, balancing leverage and opportunities.
All right. Turning to the UK, you mentioned getting to 40% of the synergies you expect. You also said something about steps taken to revamp the compensation structure and some leadership changes there. Regarding those things — the comp structure changes and the management items — how far along would you say you are in that bucket?
That's fairly recent for us. I'd say around the one-year anniversary, shifting the compensation structure so it centers on performance and results is a fairly recent change—within the last quarter, I'd say. The effect really won't show up until we move forward from here.
All right. Turning to the NHS, was there anything worth flagging this quarter regarding the progress you might have made on dialogue, or on conversations about converting disposable products to reusable ones? Again,
To my mind, that represents a chance—a really solid one—as we move ahead. I'd describe the talks as having been productive. I can't claim that 90% of our healthcare business has made the switch. What I can tell you is that we're very happy with the conversations we've held with quite a few NHS trusts and with our customers, and that includes signing several contracts again, along with their contentment regarding service, quality, and service. Everything that should be falling into place is falling into place. The following stage, without question, involves carrying on working alongside them to broaden product lines and boost conversions to reusable.
All right, I appreciate you giving me the chance to ask a few things.
Thanks, Mike.
Our next question comes as a follow-up from Cheryl Zhang at TD Cowen.
Thanks, Linda and Kristie. I have a few quick housekeeping points. First, you mentioned an interest rate swap that essentially turns your floating rate into a fixed one. I'm curious how we should think about your interest rate from here on out?
Cheryl, realistically speaking, I wouldn't expect anything major to shift from what you're already observing in the quarter.
All right, got it. And then one last thing on capex: how much of the Stellar Marion project's capex is still left to spend, and how would you expect that spending to be paced over the remainder of the year?
Looking at the larger picture, I'd say the spend that's left will likely be split fairly evenly, more or less, between Q3 and Q4. On the whole, we have about $10 million to $11 million remaining out of the total capex we guided to, and a couple million of that is probably the leftover cash payments for Stellar Marion.
All right, that's really useful. Thanks.
Thank you. At this point, we have no more questions. I'll hand things over now to Linda McCurdy, who will offer some closing remarks.
Thank you all for being here today. Should you have any additional questions afterward, don't hesitate to contact Kristie or me directly. Also, I hope each of you enjoys the remainder of the summer. Many thanks.
Ladies and gentlemen, that brings today's conference call to an end. We appreciate everyone for joining in. You're welcome to disconnect at this point.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete K-Bro Linen Inc. transcript - plus 133,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to K-Bro Linen Inc. earnings transcripts and 133,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.